Montelukast Sodium
Product Images NDC 71610-129

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 71610-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0129 09)

This is a packaging information for Montelukast Sodium tablets. Each tablet contains 10mg of the active ingredient. The package contains 9000 tablets. The NOC# is also provided for identification purposes.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard (Montelukast Fig1)

The text describes a figure showing the change in height (measured in cm) over time (in weeks) for three different treatment groups: Montelukast 5mg, Beclomethasone 336mcg, and Placebo. The figure displays the treatment group mean and standard error of the mean. The standard error values are too small to be visible in the plot.*

FDA Label Image

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N=406; Placebo N=270) (anova Model) (Montelukast Fig2)

FDA Label Image

Chemical Structure (Montelukast Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.